P3 Health Partners (PIII) Common Equity (2019 - 2025)

P3 Health Partners (PIII) has 7 years of Common Equity data on file, last reported at -$155.2 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 304.38% year-over-year to -$155.2 million; the trailing twelve-month figure through Dec 2025 stood at -$155.2 million (down 304.38% YoY), and the FY2025 full-year result was -$155.2 million, down 304.38% from the prior year.
• Common Equity for Q4 2025 stood at -$155.2 million, down from -$18.7 million in the prior quarter.
• Across five years, Common Equity topped out at $263.0 million in Q1 2022 and bottomed at -$272.9 million in Q4 2021.
• The 5-year median for Common Equity is $53.9 million (2025), against an average of $13.2 million.
• The widest annual swing landed in 2024, when Common Equity surged 5559.81%; it then plunged 304.38% in 2025.
• A 5-year view of Common Equity shows it stood at -$272.9 million in 2021, then soared by 102.14% to $5.9 million in 2022, then surged by 2327.91% to $142.1 million in 2023, then plunged by 46.57% to $75.9 million in 2024, then plunged by 304.38% to -$155.2 million in 2025.
• The last three Common Equity figures came in at -$155.2 million (Q4 2025), -$18.7 million (Q3 2025), and $44.5 million (Q2 2025), per Business Quant data.

Peer Comparison